Despite plastic surgeons innately being among some of the most creative and innovative people in medicine, there remains a significant gap between surgical innovation and technology in cosmetic medicine. For instance, the standard of care in cosmetic surgery for the last 40+ years has been the routine use of 2D photographs which serve as a reference during surgery. Unfortunately, 2D images are rarely the same scale as the patient, are difficult to compare as surgery progresses, and often times placed on the wall far from the patient or at a vantage point in which subtle details can be missed. Our founders, plastic surgeons themselves, were tired of 2D images as the only reference tools in the operating room used for determining success. They wanted a tool that catered to their desire for perfection for each patient and the 2D images were chronically failing. To fill this void, MirrorMe3D was born and our team has been creating full-color 3D-printed models and soft tissue guides for plastic surgeons across the globe. As the first company to do this, we’re dedicated to improving the plastic surgery experience for surgeons and patients by providing patient specific 3D-printed models to surgeons who won’t settle for any outcome that is less than the best. As we grow, we promise to continue to innovate and pioneer new technologies that further advance our mission: elevate the best plastic surgeons.

Despite plastic surgeons innately being among some of the most creative and innovative people in medicine, there remains a significant gap between surgical innovation and technology in cosmetic medicine. For instance, the standard of care in cosmetic surgery for the last 40+ years has been the routine use of 2D photographs which serve as a reference during surgery. Unfortunately, 2D images are rarely the same scale as the patient, are difficult to compare as surgery progresses, and often times placed on the wall far from the patient or at a vantage point in which subtle details can be missed. Our founders, plastic surgeons themselves, were tired of 2D images as the only reference tools in the operating room used for determining success. They wanted a tool that catered to their desire for perfection for each patient and the 2D images were chronically failing. To fill this void, MirrorMe3D was born and our team has been creating full-color 3D-printed models and soft tissue guides for plastic surgeons across the globe. As the first company to do this, we’re dedicated to improving the plastic surgery experience for surgeons and patients by providing patient specific 3D-printed models to surgeons who won’t settle for any outcome that is less than the best. As we grow, we promise to continue to innovate and pioneer new technologies that further advance our mission: elevate the best plastic surgeons.

From radiologists to cardiologists; neurologists to anesthetists – medical professionals around the world are opting to carry out minimally-invasive interventional procedures. The reason? A smaller entry wound and less invasive surgery leads to faster recovery times, and ultimately, better patient outcomes.

However, even though visualization, control and imaging technologies continue to evolve, current options fall short of open procedures. Moreover, having many different data sources to review during each procedure adds further complexity.

SentiAR is digital health, software device company adding a new dimension to clinical practice in interventional procedures. Spun out of Washington University, we are developing the first 3D visualization platform using real-time holography of the patient's anatomy and catheter location, ''floating'' over the patients, with a goal to provide the clinician and patient a faster, safer delivery of care. SentiAR’s mission is to transform the experience for both patient and clinician in interventional procedures with a 3D augmented reality platform featuring real-time holographic visualization of the patient’s actual anatomy, “floating” over the patient. The visualization is fully controllable “hands-free” by the clinician, providing an ergonomic breakthrough for the treatment and analysis of cardiac arrhythmias within an interventional catheter lab environment. SentiAR is developing the platform for eventual FDA submission.